openPR Logo
Press release

Top Players in Endocrinology Drugs

07-12-2021 07:39 AM CET | Health & Medicine

Press release from: Transparency Market Research

Global Endocrinology Drugs Market: Overview

With the alarming increase in the prevalence of various hormone-related medical conditions, such as hypogonadism, diabetes, hyperthyroidism, and hypothyroidism, the global market for endocrinology drugs market has been witnessing a remarkable upsurge in its overall size and valuation.

Read Report Overview: https://www.transparencymarketresearch.com/endocrinology-drugs-market.html

Since the incidence rate of diabetes is exceptionally high across the world, fueled by unhealthy diet and the reducing involvement of consumers in physical activities, the global market is likely to remain experiencing a high-paced rise in the years to come.

This exhaustive research report on the global market for endocrinology drugs offers a thorough assessment, emphasizing specifically on its past and current performance. The growth prospects of this market has also been studied in details in this report to predict its future status.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1598

Global Endocrinology Drugs Market: Trends and Opportunities

The rising number of cases of hypogonadism in men, triggered by diabetes and renal or heart disorders, is creating lucrative opportunities for market players. With the increasing intake of medications, the prospects for the market’s growth is likely to be boosted in the years to come. The increasing awareness among people pertaining to thyroid, diabetes, and other hormone-related disorders is also anticipated to drive this market in the future.

Due to the high prevalence of diabetes, the demand for diabetes drugs is higher than other products. Researchers expect this trend to remain so over the next few years, resulting in the high growth rate of the diabetes drug segment. The introduction of novel drug therapies and the presence of robust product pipelines in this market for the treatment of the both types of diabetes mellitus are likely to add significantly to the rise of this segment in the years to come.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1598

Global Endocrinology Drugs Market: Geographical Analysis

In terms of the geography, the global endocrinology drugs market boasts of its presence across Asia Pacific, the Middle East and Africa, North America, Europe, and Latin America. Owing to the rising prevalence of endocrine diseases, North America has been dominating the worldwide endocrinology drugs market. Taking the augmenting usage of hormone replacement therapies and the favorable reimbursement policies by the governments in consideration, researchers anticipate the scenario to remain same over the next few years.

Asia Pacific, amongst other, is likely to report a high-paced growth in the years to come on the grounds of the rising prevalence of growth hormone deficiency and the imminent increase in the research and development activities in this region.

The surge in the cases of diabetes and endocrine gland associated cancer, such as end stage renal disorders, is also projected to have a positive impact on the Asia Pacific market for endocrinology drugs in the near future.

Pre Book Endocrinology Drugs Market Research -https://www.transparencymarketresearch.com/checkout.php?rep_id=1598<ype=S

Companies Mentioned in the Research Report

The leading producers of endocrinology drugs are Novo Nordisk, Merck, Sanofi, AstraZeneca, Eli Lily, and AbbVie. Some of the other prominent participants in this market are HanAll BioPharma, Bayer HealthCare Pharmaceuticals, Acerus Pharmaceuticals, BHV Pharma, Acrux DDS, Biocon, GSK, Hanmi Pharmaceutical, MannKind, Intrexon, ChipScreen Biosciences, Endo Pharmaceuticals, Takeda Pharmaceuticals, Oramed Pharmaceuticals, MacroGenics, Islet Sciences, KinDex Pharmaceuticals, VeroScience, Transition Therapeutics, and Gan and Lee Pharmaceuticals.

More Trending Reports by Transparency Market Research –

Hip Replacement Implants Market: https://www.prnewswire.com/news-releases/industry-stakeholders-in-hip-replacement-implants-market-aim-at-implant-modifications-to-improve-outcomes-in-total-hip-arthroplasty-tha-tmr-301250157.html

Pressure Ulcers Treatment Market: https://www.prnewswire.com/news-releases/pressure-ulcers-treatment-market-high-incidence-of-age-related-hospital-acquired-pressure-ulcers-among-the-elderly-underscores-growth-adoption-of-biological-variants-to-gather-momentum-in-future-tmr-301256751.html

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Top Players in Endocrinology Drugs here

News-ID: 2325926 • Views:

More Releases from Transparency Market Research

Turbines Industry to Surpass USD 377.6 Billion by 2035, Expanding at 6.7% CAGR | Transparency Market Research
Turbines Industry to Surpass USD 377.6 Billion by 2035, Expanding at 6.7% CAGR | …
According to the latest industry analysis, the global turbines market, valued at US$ 185.0 billion in 2024, is projected to expand at a CAGR of 6.7% from 2025 to 2035, reaching an estimated US$ 377.6 billion by 2035. The surge in market value underscores the vital role of turbine technologies in the global energy transition, spurred by policy-driven renewable adoption, technological innovations, and a rapid expansion of wind, hydro, and
Global Water Desalination Equipment Market to Reach US$ 32.3 Billion by 2035 | Transparency Market Research
Global Water Desalination Equipment Market to Reach US$ 32.3 Billion by 2035 | T …
As the world faces an accelerating crisis of water scarcity fueled by climate change, population growth, and industrial expansion, the global water desalination equipment market is emerging as a cornerstone of sustainable water management. According to the latest market analysis, the sector was valued at US$ 13.0 billion in 2024 and is projected to expand at a CAGR of 8.6% from 2025 to 2035, reaching US$ 32.3 billion by the
North America Hydraulic Fluid Connectors Market to Reach US$ 13.4 Billion by 2035, Expanding at a CAGR of 7.9% | TMR
North America Hydraulic Fluid Connectors Market to Reach US$ 13.4 Billion by 203 …
The North America hydraulic fluid connectors market is poised for remarkable growth, rising from US$ 5.8 billion in 2024 to an estimated US$ 13.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of 7.9% between 2025 and 2035. The market's acceleration is being driven by surging infrastructure investments, industrial automation, and increasing adoption of high-performance, leak-free hydraulic systems across multiple industries. The United States maintains a dominant position
Global Calcium Carbonate Market to Reach US$ 96.7 Billion by 2035 | Expanding at a CAGR of 6.1% - TMR
Global Calcium Carbonate Market to Reach US$ 96.7 Billion by 2035 | Expanding at …
The global calcium carbonate market is witnessing steady expansion, driven by its widespread industrial usage, cost-effectiveness, and adaptability. Valued at US$ 50.5 billion in 2024, the market is projected to reach US$ 96.7 billion by 2035, growing at a compound annual growth rate (CAGR) of 6.1% between 2025 and 2035. Calcium carbonate, one of the most versatile and abundant minerals on Earth, continues to play a critical role in diverse industries

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the